Impact Factor
4.62
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
14.72
3,587 total citations
h5-index
77
h5 depth signal
Cited share
76.1%
197 of 259
Total citations
3,587
Citation footprint
Metric signal
13.06
External metric anchor
Self-citation
0.5%
19 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
532
China
156
United Kingdom
99
Germany
76
Australia
60
Citing Fields of Research
Immunology
162
Cellular Membrane Transporters & Receptors
142
Cancer, Autophagy & Apoptosis
107
Oncology
97
Cell Biology
87
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
7,510
Articles tracked across the journal lifetime
Indexed publication set
259
197 cited publications
Last 12 months
153
12.8 publications/month
Open access share
21.6%
33 OA publications in the last year
Leading citing country
United States
532 citing publications
Leading citing field
Immunology
162 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v9n1, 1988-
v9n1, 1988-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Cellular Membrane Transporters & Receptors
Neurodegenerative Disorders
Cancer, Autophagy & Apoptosis
Immunotherapy
Cell Biology
Oncology
Issuing & Sponsoring Bodies
Contributor
International Union of Pharmacology
Contributor
International Union of Toxicology
Broad Categories
Pharmacology
Cancer, Autophagy & Apoptosis
Immunology
Genetics & Genomics
Cellular Membrane Transporters & Receptors
Immunotherapy
Molecular & Cellular Toxicology
Protein Structure & Folding
MeSH Descriptors
Pharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.tips.2026.09.010
Open DOI
Perianal fistulizing Crohn’s disease: emerging biology, therapeutics, and roadmap for precision treatment
02
DOI 10.1016/j.tips.2026.09.009
Open DOI
Engineering monocytes and macrophages for therapeutic control
03
DOI 10.1016/j.tips.2026.09.005
Open DOI
Precision toxicity control in checkpoint immunotherapy
04
DOI 10.1016/j.tips.2026.09.008
Open DOI
Emerging tumor resistance mechanisms to antimetabolite treatment
05
DOI 10.1016/s0165-6147(26)00244-0
Open DOI
Subscription and Copyright Information
06
DOI 10.1016/s0165-6147(26)00240-3
Open DOI
Advisory Board and Contents
07
DOI 10.1016/j.tips.2026.09.006
Open DOI
Epigenetic programming via lysine-specific demethylase 1 regulates responses to immune checkpoint blockade
08
DOI 10.1016/j.tips.2026.09.003
Open DOI
Heterochiral peptides reshaping class B1 GPCR agonism
09
DOI 10.1016/j.tips.2026.09.002
Open DOI
Targeting CH25H restores p62-mediated α-synuclein clearance
10
DOI 10.1016/j.tips.2026.09.004
Open DOI
B cells enter the synaptic conversation
Bibliographical & Catalog Notes
Edition statement supplied.
Supplements accompany some volumes.
Also available online.
Vols. for 1979-<Jan. 82> published in association with the International Union of Pharmacology; for <1983-> in association with the International Union of Pharmacology and the International Union of Toxicology.
Supplement for 1990-1993 called: Receptor nomenclature supplement, shelved with the main journal at NLM.
Also issued in an annual compilation called: Reference ed.
Vol. 10, no. 1 (JAN 1989)19900917 Notice not published Printed on acid-free paper